159 related articles for article (PubMed ID: 38617617)
1. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients.
Ou M; Zhang W; Zhang W; Guo J; Huang R; Wang J; Liu J; Xia J; Wu C; Zhu Y; Chen Y
ACS Omega; 2024 Apr; 9(14):16716-16724. PubMed ID: 38617617
[No Abstract] [Full Text] [Related]
2. Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B.
Zhou L; Li X; Huang X; Chen L; Gu L; Huang Y
J Viral Hepat; 2019 Jul; 26(7):795-802. PubMed ID: 30578715
[TBL] [Abstract][Full Text] [Related]
3. High levels of soluble programmed death-1 are associated with virological response in chronic hepatitis B patients after antiviral treatment.
Tan N; Luo H; Kang Q; Pan J; Cheng R; Xi H; Chen H; Han Y; Yang Y; Xu X
Virus Res; 2022 Feb; 309():198660. PubMed ID: 34929214
[TBL] [Abstract][Full Text] [Related]
4. [Significance of soluble PD-L1 in patients with chronic hepatitis B and hepatitis C].
Ke RM; Ouyang LJ; Li WF; Peng XM
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):133-137. PubMed ID: 37137827
[No Abstract] [Full Text] [Related]
5. Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment.
Tan N; Luo H; Kang Q; Pan JL; Cheng R; Xi HL; Chen HY; Han YF; Yang YP; Xu XY
World J Clin Cases; 2021 Jul; 9(21):5812-5821. PubMed ID: 34368300
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract][Full Text] [Related]
7. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
[TBL] [Abstract][Full Text] [Related]
8. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm.
Zhou JY; Song LW; Yuan R; Lu XP; Wang GQ
World J Gastroenterol; 2021 Jun; 27(21):2910-2920. PubMed ID: 34135561
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
10. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
[TBL] [Abstract][Full Text] [Related]
11. Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal.
Chen S; Huang H
Front Med (Lausanne); 2021; 8():661725. PubMed ID: 34150800
[No Abstract] [Full Text] [Related]
12. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
[No Abstract] [Full Text] [Related]
13. Serum sCD14 as a Biomarker for Significant Liver Inflammation in Chronic Hepatitis B Patients with Normal or Mildly Elevated ALT.
Yang K; Pan Y; Yan B; Yu FR; Chen J; Liu P; Tian PP; Zhang H; Zhang FS
Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655210
[TBL] [Abstract][Full Text] [Related]
14. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
15. A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
Chen S; Huang H; Huang W
BMC Gastroenterol; 2021 Jan; 21(1):4. PubMed ID: 33407146
[TBL] [Abstract][Full Text] [Related]
16. Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.
Deng YQ; Zhao H; Ma AL; Zhou JY; Xie SB; Zhang XQ; Zhang DZ; Xie Q; Zhang G; Shang J; Cheng J; Zhao WF; Zou ZQ; Zhang MX; Wang GQ;
Medicine (Baltimore); 2015 Nov; 94(45):e2003. PubMed ID: 26559292
[TBL] [Abstract][Full Text] [Related]
17. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
18. The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays.
Jeng WJ; Chen CH; Wang YW; Pan MH; Lin CW; Lin CY; Yang HI
Virol J; 2022 Mar; 19(1):59. PubMed ID: 35361235
[TBL] [Abstract][Full Text] [Related]
19. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
20. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
